About: Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 16 May 2020

Attributes	Values
rdf:type	Item
description	article scientifique publié en 2020 (fr) artículu científicu espublizáu en mayu de 2020 (ast) im Mai 2020 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована 16 травня 2020 (uk) artykuł naukowy opublikowany 16 maja 2020 (pl) scientific article published on 16 May 2020 (en)
publication date	wds:Q95262851-3040639A-7D7E-4B7F-B3FC-6C2E9DD9B67A
publication date	2020-05-16 00:00:00Z (xsd:dateTime)
cites work	wds:Q95262851-016B841F-1EB0-464A-9C2B-664A7C9AF446 wds:Q95262851-0BB3FBC1-A747-4A35-84C7-7507B67788D7 wds:Q95262851-0CB877E8-63CC-4D03-AEBA-024A51D289AB wds:Q95262851-0D7C3854-98B6-4B41-8BFC-352359A931B5 wds:Q95262851-38D4CBA1-75C9-430C-889E-C8C324711381 wds:Q95262851-531788C8-B089-4E1F-9D21-3AD132C9B683 wds:Q95262851-573BD2E0-E39F-4DCA-8DBC-F7F08644B483 wds:Q95262851-6509A75D-3F4B-420A-99D8-D2E0F1AA7B85 wds:Q95262851-6A705468-F0F0-4E46-B8AD-DDD887A686FB wds:Q95262851-6BC86CF6-8E3A-4D65-B895-0B2ABB27D97D wds:Q95262851-6F14FBC1-7814-42E4-8B49-D20558914B67 wds:Q95262851-73F54ACC-A8B3-4F7F-AD6A-6A2C2A0ACA39 wds:Q95262851-8584512F-B534-4C06-B95F-8D6412992866 wds:Q95262851-92E47BD6-E2F6-43D2-8722-E7E95EA69053 wds:Q95262851-ACC07065-082E-47E9-8BB2-F4FC3F2CF1F6 wds:Q95262851-B5F4F057-7646-41F2-A692-100CA8E4EDE0 wds:Q95262851-B8C1393B-A675-4322-8FCE-2ED5F072E49B wds:Q95262851-BA98432E-A1CD-4762-AB33-F09A6CBFA3F4 wds:Q95262851-C7A4F9A6-51E9-449D-8955-58B4169B77EE wds:Q95262851-E631B3F5-1E41-439C-824C-98342862D7D6 wds:Q95262851-EAEFB9E2-715B-4D4C-83AE-C787ACE5B516 wds:Q95262851-EB546200-894E-444A-9E89-23AA07CCBDA1 wds:Q95262851-ED568830-118F-4772-9FF4-4EBA49DCF7AB wds:Q95262851-F2C296D1-72DD-4596-8384-8776C6F64A82 wds:Q95262851-F5B2813C-784F-422D-8D4A-014E7DFBC71A wds:Q95262851-FCC30D15-F0B6-4E11-B8D9-AABE4E0D5C68 wds:Q95262851-FFC94AD5-FDD0-4AEF-A895-AD8B41084183
cites work	High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study Adverse effects of biologics: a network meta-analysis and Cochrane overview Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies Baricitinib as potential treatment for 2019-nCoV acute respiratory disease Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 Why tocilizumab could be an effective treatment for severe COVID-19? Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission Chloroquine and hydroxychloroquine in covid-19 Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients. Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/Covid-19 pandemic The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
author name string	wds:Q95262851-1B57E1AA-44A7-46E1-A391-261A2B6D2AA9 wds:Q95262851-225EA8D6-2268-403F-80B3-ADD47426019A wds:Q95262851-28F03045-91D0-4E7F-ACEE-3888CD54F145 wds:Q95262851-3221BDD4-72B8-4EF0-9B5C-6BC41CA41AC3 wds:Q95262851-372FD0C4-6AC3-4B99-8DF8-F080E2F2F324 wds:Q95262851-3BDD0E22-994B-430A-9C46-AF6FE3EC7CBC wds:Q95262851-5565D0E7-249E-47F1-B0CC-A6B70E43F0D9 wds:Q95262851-70663748-4DB1-4210-A6E7-F9555405C236 wds:Q95262851-7570771D-6B9E-4C1A-BC36-308C07D698EE wds:Q95262851-7A9DD632-AAF6-4BC6-8187-320F116CC8EA wds:Q95262851-89CDBBA8-E632-4179-9F81-843D2A516FDE wds:Q95262851-C2654CC4-7AC1-4F4D-B43F-2BFA724BD79B wds:Q95262851-C2F987BF-1268-40D5-BC08-C30B04FEBC73 wds:Q95262851-C376DFC0-A971-4C5C-BB2F-9D99B3F2D1CD wds:Q95262851-CC16F59F-E5DE-463A-9137-DCB349EC9223 wds:Q95262851-CFB19354-012E-473C-948D-9C747BBD9522 wds:Q95262851-D5825C87-9B95-4F1A-9751-B9EA29E4D2F1 wds:Q95262851-E92DDDC8-1B2F-4A92-A74A-19899A095C50 wds:Q95262851-EC366000-A958-4A71-9F64-8758EBFA9ABE wds:Q95262851-FA9D4AED-54A6-46AF-821A-6602F11334DA
author name string	Estefanía Moreno Antonio Julià Alba Erra Sara Marsal Ernesto Trallero-Araguás Miriam Almirall María López-Lasanta Andrea Pluma Mireia López-Corbeto Esther Espartal Gustavo Adolfo Añez Helena Borrell Jordi Lladós Segura Juan José De Agustín María Pascual-Pastor Mayte Serrat Mireia Barceló-Bru

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software